
BLRX Stock Price Prediction
BioLine RX Ltd
- Overview
- Forecast
- Valuation
- Earnings
1-Day-Price-Prediction
-0.43%
1-Week Prediction
+2.62%
Based on our advanced algorithm, we predict that BLRX stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $4.49, while the 1-week outlook suggests a value of $4.63. For the 1-month forecast, we project a price of $4.75. Looking further ahead, our 2026 projection estimates a value of $5.16, with a long-term 2030 forecast reaching $10.45. Stay informed and make strategic decisions with our data-driven insights!
4.750
Should I Buy BioLine RX Ltd Stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. BLRX has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
BLRX stock price ended at $4.51 on Thursday, after losing -1.1%
The BioLine RX Ltd stock price decreased by -1.1% on the last trading day (24 Jul 2025), dropping from 4.56 to 4.51. Throughout the last trading session, the stock experienced a fluctuation of 3.30% , ranging from a day low of $4.4335 to a day high of 4.58. The price has declined in 5 of the last 10 days, resulting in a total change of -7.58% during this period. On the last day, trading volume increase by -15.01K shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 26.02K shares were traded, amounting to approximately 117.53K.
BLRX Technical Signals
BLRX(BioLine RX Ltd Corp) has 1 buy signal and 3 sell signals now. The current trend is downtrend starting from 2025-07-10. The total price change during this trend is -7.58%. Recently, the price has decreased but the volume has also decreased, indicating a potential rebound signal. The average turnover of BLRX over the last 5 trading days is 162.25K. Overall, the technical indicator signals lean more toward a Bearish outlook in the mid-term.
BLRX Moving Average Analysis
BioLine RX Ltd's overall moving average trend leans more bearish as of Friday, July 25, 2025, with 2 negative signals and 2 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $4.98, and $5.24. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $4.16, and $3.91. A break-down below any of these levels will issue sell signals.
BLRX Short Selling Analysis
The short sale ratio of BioLine RX Ltd(BLRX) as of 23 Jul 2025 is 13.57%, dropping from last trading day. With decreasing price from 4.49 to 4.56. The short sell activity indicate that short sellers may be experiencing short cover.
Technical Signal
Technical Signals Summary

Sell
Sell
3
Buy
1
Moving Average
Swing

Stock Price Above SMA_5
Short Term

SMA_5 Below SMA_20
Mid Term

SMA_20 Above SMA_60
Long Term

SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
1 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.0221
Bullish
3 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 < 0
-0.237
Bearish
Momentum (10 days)
MOM_10 < 0
-0.37
Bearish
Moving Average
Price crosses below 20-day SMA
--
Bearish
BLRX Stock Forecast
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
In 2026, BioLine RX Ltd (BLRX) is anticipated to change hands in a trading channel between $3.45 and $6.02.
BioLine RX Ltd Stock Forecast 2026
Jan 2026: BLRX Stock Forecast
Potential ROI: 19.76%
In Jan 2026, BioLine RX Ltd's value is forecasted to reach an average price of $5.38. The price is predicted to fluctuate between a low of $4.74 and a high of $5.51.
Feb 2026: BLRX Stock Forecast
Potential ROI: 7.68%
In Feb 2026, BioLine RX Ltd's value is forecasted to reach an average price of $4.83. The price is predicted to fluctuate between a low of $4.50 and a high of $5.31.
Mar 2026: BLRX Stock Forecast
Potential ROI: 13.54%
In Mar 2026, BioLine RX Ltd's value is forecasted to reach an average price of $5.10. The price is predicted to fluctuate between a low of $4.94 and a high of $5.61.
Apr 2026: BLRX Stock Forecast
Potential ROI: 0.83%
In Apr 2026, BioLine RX Ltd's value is forecasted to reach an average price of $4.53. The price is predicted to fluctuate between a low of $4.28 and a high of $5.08.
May 2026: BLRX Stock Forecast
Potential ROI: 1.21%
In May 2026, BioLine RX Ltd's value is forecasted to reach an average price of $4.54. The price is predicted to fluctuate between a low of $3.93 and a high of $4.75.
Jun 2026: BLRX Stock Forecast
Potential ROI: 18.59%
In Jun 2026, BioLine RX Ltd's value is forecasted to reach an average price of $5.32. The price is predicted to fluctuate between a low of $4.66 and a high of $6.02.
Jul 2026: BLRX Stock Forecast
Potential ROI: 14.90%
In Jul 2026, BioLine RX Ltd's value is forecasted to reach an average price of $5.16. The price is predicted to fluctuate between a low of $4.52 and a high of $5.37.
Aug 2026: BLRX Stock Forecast
Potential ROI: -11.76%
In Aug 2026, BioLine RX Ltd's value is forecasted to reach an average price of $3.96. The price is predicted to fluctuate between a low of $3.45 and a high of $4.54.
Sep 2026: BLRX Stock Forecast
Potential ROI: 10.91%
In Sep 2026, BioLine RX Ltd's value is forecasted to reach an average price of $4.98. The price is predicted to fluctuate between a low of $4.59 and a high of $5.00.
Oct 2026: BLRX Stock Forecast
Potential ROI: 8.86%
In Oct 2026, BioLine RX Ltd's value is forecasted to reach an average price of $4.89. The price is predicted to fluctuate between a low of $4.57 and a high of $5.21.
Nov 2026: BLRX Stock Forecast
Potential ROI: 5.37%
In Nov 2026, BioLine RX Ltd's value is forecasted to reach an average price of $4.73. The price is predicted to fluctuate between a low of $4.47 and a high of $5.11.
Dec 2026: BLRX Stock Forecast
Potential ROI: 2.86%
In Dec 2026, BioLine RX Ltd's value is forecasted to reach an average price of $4.62. The price is predicted to fluctuate between a low of $4.26 and a high of $4.97.
BLRX Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to BioLine RX Ltd(BLRX), our algorithm predicts BLRX's 1-month price at $4.97, with an 11.25%upwardshift. Using a similarity score up to 95.21%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for BioLine RX Ltd (BLRX.O) stock, as of Sunday, July 20, 2025 , forecasts a 11.25% change over the next month, based on its high correlation with VLRS.N stock patterns. The similarity between their price movements over the analyzed periods is 95.21%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.

BLRX
Future prediction
Up: 11.25%

VLRS
Up: 11.25%Similarity: 95.21%
Name
Similarity
Up/Down

VLRS.N
95.21%
+11.25%

RNAZ.O
94.89%
-1.50%

OLMA.O
94.56%
-19.30%

BNED.N
94.40%
-72.86%

AMPX.N
94.36%
-1.25%

CDW.O
94.33%
+6.30%

VRSN.O
94.33%
+4.85%

CTLP.O
94.31%
+11.54%

PAR.N
94.30%
+10.00%

HSDT.O
94.23%
-28.46%
BLRX Seasonality Analysis
Based on BLRX's historical stock price data across all years, the probability of a positive return in July is50.00%, suggesting it maybe an ideal month to invest in BLRX. In contrast,Mayoffers the highest probability of positive returns at60.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying BioLine RX Ltd (BLRX.O) stock in May has the highest probability of a positive return (60.00%), while October has the lowest probability (20.00%).
Performance Seasonality
The chart shows BioLine RX Ltd. (BLRX)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch

GASS
StealthGas Inc
6.680
USD
-1.91%

SMID
Smith-Midland Corp
36.830
USD
-2.15%

OVLY
Oak Valley Bancorp
27.500
USD
-2.27%

FVCB
FVCBankcorp Inc
13.250
USD
-3.50%

ODV
Osisko Development Corp
2.420
USD
-1.63%

FXNC
First National Corp
21.740
USD
-1.54%

MFIN
Medallion Financial Corp
9.600
USD
-0.31%

DC
Dakota Gold Corp
4.080
USD
-2.86%

SKIN
Beauty Health Co
1.830
USD
-9.41%

BLFY
Blue Foundry Bancorp
8.970
USD
-1.54%
FAQ

Should I buy BioLine RX Ltd (BLRX.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. BLRX has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.

Which months have the highest win rate for buying BioLine RX Ltd (BLRX.O) stock in a year?

How has BioLine RX Ltd. (BLRX)'s stock price performed over the past three years?

Which bull technical signals does BLRX have?

Which bearish technical signals does BLRX have?

Is BLRX a buy based on overall technical signals summary?

What is the trend of BioLine RX Ltd (BLRX)'s moving average?

What is price prediction for BLRX stock next month?

What is price prediction 2025 for BLRX Stock?
